Shares of Questcor (NASDAQ: QCOR) closed down 7% today, after Blue Cross Blue Shield Michigan came out against Acthar Gel in all indications except for infantile spasm. In this video, Motley Fool health-care analyst David Williamson dives into today's news, and explains what it means for investors going forward.
Blue Cross Blue Shield Michigan stirs the pot.
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid